About Us
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
|
|
|
ABEO - Abeona Therapeutics ...| Previous Close | $1.98 | Open | $1.99 |
| Volume | 2.17M | Market Cap | 195.08M |
| Yield | Last Dividend |
| Why This Abeona Therapeutics Analyst Is ... | 11/11/20 |
| Abeona Therapeutics Inc???s (NASDAQ: ABEO ) stock does not reflect the company???s in-house manufacturing capabilities and pipeline, according to Cant... | |
| Abeona Therapeutics Reports Third Quarte... | 11/09/20 |
| Conference call scheduled for Tuesday, November 10, 2020 at 8:30 a.m. ET | |
| The Daily Biotech Pulse: Alzheimer's Con... | 11/04/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Nov. 3) Bio-... | |
| Abeona Therapeutics (NASDAQ:ABEO) Stock ... | 10/24/20 |
| Abeona Therapeutics Inc (NASDAQ:ABEO) shares rose 5.5% during trading on Friday . The company traded as high as $1.37 and last traded at $1.34. Approx... | |
| The Daily Biotech Pulse: Amag Spikes On ... | 10/01/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 30) Ac... | |
| The Daily Biotech Pulse: FDA Nod For Pfi... | 09/29/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 28) 10... | |
| Abeona Therapeutics Reports Second Quart... | 08/10/20 |
| Additional patients dosed in RDEB, MPS IIIA and MPS IIIB clinical programs General alignment with CHMP on plans for EU registration of ABO-102 for MPS... | |
| Is Abeona Therapeutics (ABEO) Outperform... | 05/28/20 |
| Is (ABEO) Outperforming Other Medical Stocks This Year? | |
| The Week Ahead In Biotech: Virtual Confe... | 05/10/20 |
| The smid-cap biotech earnings deluge hit Wall Street in the week ended May 9, positively impacting the stocks in the sector. The iShares NASDAQ Biotec... | |
| Moving Average Crossover Alert: Abeona T... | 04/29/20 |
| Abeona Therapeutics is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average ... | |
| Is a Beat in Store for Abeona (ABEO) Thi... | 04/24/20 |
| Abeona's (ABEO) operating expenses are expected to have increased in the first quarter driven by clinical studies on its lead gene therapy candidate. | |
| Implied Volatility Surging for Abeona Th... | 04/20/20 |
| Investors need to pay close attention to Abeona Therapeutics (ABEO) stock based on the movements in the options market lately. | |
| Is Abeona Therapeutics (ABEO) Stock a So... | 04/06/20 |
| Abeona Therapeutics (ABEO) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well. | |
| Abeona Treats First Patient in Pivotal G... | 03/18/20 |
| Abeona (ABEO) treats first patient in a pivotal study evaluating its gene-corrected cell therapy, EB-101, as a treatment for recessive dystrophic epid... | |
| Abeona Therapeutics (ABEO) Moves to Buy:... | 02/11/20 |
| Abeona Therapeutics (ABEO) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (B... | |
| THURSDAY DEADLINE ALERT: The Schall Law ... | 01/02/20 |
| LOS ANGELES--(BUSINESS WIRE)---- $ABEO #ABEO--THURSDAY DEADLINE ALERT: The Schall Law Firm Announces it is Investigating Claims Against Abeona Therape... | |
| THURSDAY DEADLINE: The Schall Law Firm A... | 12/31/19 |
| Investors who purchased the Company's securities between May 31, 2018 and September 23, 2019, inclusive (the ''Class Period''), are encouraged to cont... | |
| 6-Day Deadline Alert: The Schall Law Fir... | 12/27/19 |
| Investors who purchased the Company's securities between May 31, 2018 and September 23, 2019, inclusive (the ''Class Period''), are encouraged to cont... | |
| DEADLINE ALERT: Bragar Eagel & Squire, P... | 12/27/19 |
| NEW YORK--(BUSINESS WIRE)-- #abeo--Bragar Eagel & Squire, P.C., a nationally recognized shareholder law firm, reminds investors that a class action la... | |
| FINAL DEADLINE APPROACHING: The Schall L... | 12/20/19 |
| LOS ANGELES, CA / ACCESSWIRE / December 20, 2019 / The Schall Law Firm ,a national shareholder rights litigation firm, announces the filing of a class... | |
| The Daily Biotech Pulse: Axovant Surges ... | 12/20/19 |
| The following is a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that hit 52-week highs D... | |
| SHAREHOLDER NOTICE: The Schall Law Firm ... | 12/12/19 |
| Investors who purchased the Company's securities between May 31, 2018 and September 23, 2019, inclusive (the ''Class Period''), are encouraged to cont... | |
| Abeona Therapeutics to Initiate Phase 3 ... | 12/09/19 |
| The company announced that the US Food and Drug Administration has removed its clinical hold on its Phase 3 clinical trial of EB-101. The post Abeona ... | |
| Bronstein, Gewirtz & Grossman, LLC Remin... | 12/09/19 |
| NEW YORK, NY / ACCESSWIRE / December 9, 2019 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against... | |
| The Gene Therapy Names Moving On The Aud... | 12/03/19 |
| Gene therapy company Audentes Therapeutics Inc (NASDAQ: BOLD ) announced a deal late Monday to be acquired by Japanese pharma company ASTELLAS PHARMA/... | |
| SHAREHOLDER ACTION NOTICE: The Schall La... | 11/27/19 |
| LOS ANGELES, CA / ACCESSWIRE / November 27, 2019 / The Schall Law Firm ,a national shareholder rights litigation firm, announces the filing of a class... | |
| Bronstein, Gewirtz & Grossman, LLC Remin... | 11/25/19 |
| NEW YORK, NY / ACCESSWIRE / November 25, 2019 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed agains... | |
| IMPORTANT INVESTOR ALERT: The Schall Law... | 11/22/19 |
| LOS ANGELES, CA / ACCESSWIRE / November 22, 2019 / The Schall Law Firm ,a national shareholder rights litigation firm, announces the filing of a class... | |
| ABEO ALERT: Zhang Investor Law Reminds I... | 11/21/19 |
| Zhang Investor Law announces a securities class action lawsuit on behalf of shareholders who bought shares of Abeona Therapeutics Inc. (ABEO) between ... | |
| Class Action Notification - Abeona Thera... | 11/20/19 |
| NEW YORK, NY / ACCESSWIRE / November 20, 2019 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed agains... | |
| Buy rating | 11/25/20 |
| HC Wainwright & Co. maintains Buy rating and lowers Price Target from $11.00 to $8.00 | |
| Strong Buy rating | 11/11/20 |
| Cantor Fitzgerald upgrades from Neutral to Overweight rating and announces Price Target of $4.00 | |
| Strong Buy rating | 11/10/20 |
| SVB Leerink maintains Outperform rating and lowers Price Target from $8.00 to $5.00 | |
| Date | 04/12/2019 (AMC) | Est. (EPS/Rev.) | $1.37 |
| Actual (EPS/Rev.) | $2.5B | EPS (TTM) | $??? |
| Total Revenue | $1.3B | Total Liabilities | $2.1B |
| Cost of Revenue | $2.5B | Total cash flow | $3.2 |
| Total Assets | $29.98B |
| % Insider | 12.52% | % Institutional | 76.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Service Name | Trader | % Success | |
|---|---|---|---|
| Silent swinger | hasmat | 41.00 % | Follow |
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.
